Anthony Butler Quotes (7 Quotes)

The entire drug group is not exactly having a stellar performance and may not until the second half of 2002 when we expect a number of positive catalysts, in the form of drug approvals, to emerge within the sector,

It's certainly not a shock to me, and I don't think it would be a shock to anyone on Wall Street that the number of lawsuits has increased.

While the specific product revenues of the Consumer Healthcare business are largely unknown, we note that the PCH Pfizer Consumer Health business operates at generally lower margins than the company's pharmaceuticals business.

Thus, if the consumer business were to be sold, or perhaps restructured into a JV contributing below Pfizer's operating line, it would likely have the effect of increasing gross margins and operating margins.

While Pfizer's cash flow would likely be impacted by the loss or change in structure, we note that a partnership with another consumer health business could create increased clout for shelf space and thus operate with new synergies.

It strikes me as being unique that a company can see half a billion dollars in income go away and see it as a relatively small impact on earnings per share.

There's a rarely a day that goes by where there's not a negative story about a drug company. The only thing that's been delivered to the public is negative information, and it leaves the public with a sorry taste in its mouth.